Analysts/Institutional Investor Meet/Con. Call Updates

August 18, 2026 Ref:- GHL/2026-27/EXCH/41 The General Manager The Manager Dept. of Corporate Services Listing Department BSE Limited, National Stock Exchange of India Limited P J Towers, Dalal Street, Exchange Plaza, C-1, Block G, Mumbai - 400 001 Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 Scrip Code: 543654 Symbol: MEDANTA Sub: Intimation for Schedule of Analyst/Institutional Investor Meeting. Dear Sir(s), Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company’s Management will meet Investor/Analyst in Meeting organised as per the below schedule: Name Date of Meeting Type of Meeting Mode of Meeting FIRST RAY CAPITAL, August 21, 2026 one to one Virtual SINGAPORE Please note that, no Unpublished Price Sensitive Information is proposed to be shared, thereat. Note: Please note that the above meeting is subject to change in case of any unforeseen circumstances, on the part of Analysts/Investors/Company. Kindly take the above on record. For Global Health Limited Rahul Ranjan Company Secretary & Compliance Officer M. No. A17035 Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319